touchPODCAST

touchPODCAST

By touchpodcastScience
Download on the App Store

touchPODCAST episodes

  • AAAAI 2022: Improving outcomes for patients with eosinophilic esophagitis

    touchCONGRESS for touchRESPIRATORY

    Listen to Dr Evan Dellon (USA) cover key data presented at AAAAI 2022 Annual Meeting on eosinophilic esophagitis (EoE) including risk factors and pathogenesis, burden of disease and emerging treatment options, as well as expert insights and interpretation from Dr Stuart Carr (Abu Dhabi, UAE) and Dr Alexandra Papadopoulou (Greece).

    Overview

    • Data review with Dr Evan Dellon (00:55)
  • Expert interview with Dr Evan Dellon, Dr Stuart Carr and Dr Alexandra Papadopoulou (37:05)

    • Interview questions

    • How do the latest data improve our understanding of the pathogenesis of EoE and what are the implications for practice? (37:40)
  • How do the latest data on overlapping atopic conditions in patients with EoE correspond to the patients you manage? (42:23)
  • What are the clinical implications of the data presented from the three-part, phase III trial evaluating dupilumab in patients with EoE? (48:12)
  • Are the presented data on the use of single or multiple biologics in patients with overlapping atopic conditions encouraging? (53:18)
  • What is your key takeaway from AAAAI 2022? (58:27)

    • This touchPODCAST is for HCPs only.  

    This activity is funded by an unrestricted independent medical educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is provided by touchIME.    

    For further information visit our website: https://touchrespiratoryime.org/eoe-aaaai-2022/

    1 hr 3 min
  • AAAAI 2022: Improving outcomes for patients with eosinophilic esophagitis

    touchCONGRESS for touchRESPIRATORY

    Listen to Dr Evan Dellon (USA) cover key data presented at AAAAI 2022 Annual Meeting on eosinophilic esophagitis (EoE) including risk factors and pathogenesis, burden of disease and emerging treatment options, as well as expert insights and interpretation from Dr Stuart Carr (Abu Dhabi, UAE) and Dr Alexandra Papadopoulou (Greece).

    Overview

    • Data review with Dr Evan Dellon (00:55)
  • Expert interview with Dr Evan Dellon, Dr Stuart Carr and Dr Alexandra Papadopoulou (37:05)

    • Interview questions

    • How do the latest data improve our understanding of the pathogenesis of EoE and what are the implications for practice? (37:40)
  • How do the latest data on overlapping atopic conditions in patients with EoE correspond to the patients you manage? (42:23)
  • What are the clinical implications of the data presented from the three-part, phase III trial evaluating dupilumab in patients with EoE? (48:12)
  • Are the presented data on the use of single or multiple biologics in patients with overlapping atopic conditions encouraging? (53:18)
  • What is your key takeaway from AAAAI 2022? (58:27)

    • This touchPODCAST is for HCPs only.

    This activity is funded by an unrestricted independent medical educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is provided by touchIME.    

    For further information visit our website: https://touchimmunologyime.org/eoe-aaaai-2022/

    1 hr 3 min
  • Unlocking CSU pathogenesis to shape the future treatment landscape

    touchPANEL DISCUSSION for touchIMMUNOLOGY

    Listen to a panel of experts discuss how emerging endotypes in chronic spontaneous urticaria are driving the development of much-needed new treatment and management approaches.

    The experts:

    • Prof. Dr med. Marcus Maurer – Charité University Medicine, Berlin, Germany
  • Dr Melinda Gooderham – SKiN Centre for Dermatology, Ontario, Canada
  • Prof. David Khan – Southwestern Medical Center, University of Texas, USA

    • This touchPODCAST is for HCPs only. 

    This activity is funded by an unrestricted independent educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.

    For further information visit our website: https://touchimmunologyime.org/csu-pathogenesis-to-treatment/ 

    39 min
  • Identifying, diagnosing and treating patients with later-onset SMA

    touchTALKS for touchRESPIRATORY 

    Listen to Dr Parsons of the University of Colorado, Aurora, CO, USA, describe the clinical presentation and diagnosis of later-onset phenotypes of SMA, before reviewing clinical trial data for approved treatments and assessing their impact on the natural history of the disease.

    This touchPODCAST is for HCPs only.

    This activity is funded by an unrestricted independent medical education grant from Genentech, a member of the Roche group, and Novartis Gene Therapies, Inc. This activity is jointly provided by USF Health and touchIME.

    For further information visit our website: https://touchrespiratory.com/cme/later-onset-SMA-diagnosis-treatment

    36 min
  • Identifying, diagnosing and treating patients with later-onset SMA

    touchTALKS for touchNEUROLOGY 

    Listen to Dr Parsons of the University of Colorado, Aurora, CO, USA, describe the clinical presentation and diagnosis of later-onset phenotypes of SMA, before reviewing clinical trial data for approved treatments and assessing their impact on the natural history of the disease.

    This touchPODCAST is for HCPs only

    This activity is funded by an unrestricted independent medical education grant from Genentech, a member of the Roche group, and Novartis Gene Therapies, Inc. This activity is jointly provided by USF Health and touchIME.

    For further information visit our website: https://touchneurology.com/cme/later-onset-SMA-diagnosis-treatment

    36 min
  • The relationship between people living with HIV and their multidisciplinary team for optimal adherence to ART

    touchMDT for touchINFECTIOUSDISEASES

    Listen to an HIV specialist, a specialist nurse and an advocate for PLHIV discuss the important role of the multidisciplinary team in optimizing adherence to ART and health of PLHIV

    The experts

    • HIV Specialist: Dr Laura Waters, London, UK
  • Nurse Specialist; Ms Catarina Esteves, Cascais, Portugal
  • Advocate for PLHIV: Ms Susan Cole, London, UK

    • This touchPODCAST is for HCPs only. 

    This activity is funded by an unrestricted independent medical education grant from ViiV Healthcare UK Ltd. This activity is provided by touchIME.

    For further information visit our website:  https://touchinfectiousdiseases.com/education/mdt-hiv-art-adherence/

    14 min
  • Long-term ART adherence, comorbidities and quality of life for people living with HIV

    touchMDT for touchINFECTIOUSDISEASES

    Listen to an HIV specialist, a specialist nurse and an advocate for PLHIV discuss factors impacting quality of life and adherence to ART in PLHIV.

    The multidisciplinary team

    • HIV Specialist: Dr Laura Waters, London, UK
  • Nurse Specialist; Ms Catarina Esteves, Cascais, Portugal
  • Advocate for PLHIV: Ms Susan Cole, London, UK

    • This touchPODCAST is for HCPs only. 

    This activity is funded by an unrestricted independent medical education grant from ViiV Healthcare UK Ltd. This activity is provided by touchIME.

    For further information visit our website: https://touchinfectiousdiseases.com/education/mdt-hiv-art-adherence/

    16 min
  • Assessing readiness to initiate ART to maximize adherence

    touchMDT for touchINFECTIOUSDISEASES

    Listen to an HIV specialist, a specialist nurse and a clinical pharmacist discuss how they assess readiness to start ART and barriers to adherence.

    The multidisciplinary team

    • HIV Specialist: Dr Laura Waters, London, UK 
  • Nurse Specialist; Ms Catarina Esteves, Cascais, Portugal
  • Clinical Pharmacist: Ms Fiona Marra, Glasgow, UK 

    • This touchPODCAST is for HCPs only. 

    This activity is funded by an unrestricted independent medical education grant from ViiV Healthcare UK Ltd. This activity is provided by touchIME.

    For further information visit our website: https://touchinfectiousdiseases.com/education/mdt-hiv-art-adherence/

    14 min
  • Overcoming barriers to PrEP to optimize uptake and adherence

    touchMDT for touchINFECTIOUSDISEASES

    Listen to an HIV specialist and clinical pharmacist discuss PrEP and how factors affecting adherence may be overcome in different populations at risk of HIV infection.  

    The multidisciplinary team

    • HIV Specialist: Dr Laura Waters, London, UK
  • Clinical Pharmacist: Ms Fiona Marra, Glasgow, UK 

    • This touchPODCAST is for HCPs only. 

    This activity is funded by an unrestricted independent medical education grant from ViiV Healthcare UK Ltd. This activity is provided by touchIME.

    For further information visit our website: https://touchinfectiousdiseases.com/education/mdt-hiv-art-adherence/

    15 min
  • Sharing data to improve outcomes in LACC: What’s on the horizon?

    touchMDT for touchONCOLOGY

    Listen to a gynaecologic oncologist, a clinical oncologist, and a radiation oncologist discuss the role of the MDT in implementing change to best practice care and the importance of keeping up to date with the latest clinical trial data.

    The multidisciplinary team

    • Gynaecologic oncologist: Prof. Bradley Monk, USA
  • Clinical oncologist: Dr Mary McCormack, UK
  • Radiation oncologist: Prof. Cyrus Chargari, France

    • This touchPODCAST is for HCPs only.

    This activity is funded by an unrestricted independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.

    For further information visit our website: https://touchoncologyime.org/optimizing-mdt-care-for-locally-advanced-cervical-cancer/

     

    13 min

About touchPODCAST

From the publisher's feed

Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites.